Anand Krishnan is Principal Investigator in Chemical Pathology at the Faculty of Health Sciences, University of the Free State, South Africa, where he leads the Precision Medicine Integrative Nano Diagnostics (P-MIND) laboratories. His research focuses on the biological functions of extracellular vesicles in synthetic biology, including cell surface protein modification, biomarker discovery using liquid biopsy-derived extracellular vesicles, and the role of circulating biomarkers in disease development and stem cell biology. He leads multidisciplinary research in precision medicine and nanoscale diagnostics, with a particular interest in translational applications of extracellular vesicle science. Krishnan is an active member of the International Society for Extracellular Vesicles, the African Organisation for Research and Training in Cancer, and the American Association for Cancer Research. He has also served in editorial roles supporting scientific research and publishing. Professor Mamello Sekhoacha is an Associate Professor of Pharmacology at the University of the Free State and a former Specialist Scientist at the South African Medical Research Council. She earned her Ph.D. in Pharmacology from the University of Cape Town in 2008 and holds a BSc in Biochemistry and Microbiology, an honors degree in Pharmacology, and a Postgraduate Diploma in Business Administration. Additionally, she is a qualified Clinical Research Associate (CRA) with expertise in Ethics and Governance and Executive Leadership in Academia.With over 18 years in pharmacology research, Prof. Sekhoacha focuses on drug discovery and the scientific development of medicinal plants for treating ailments like cancer and HIV. Her research addresses challenges in chemoresistance and toxicity, exploring personalized chemotherapy and targeted drug delivery systems. She has published extensively in pharmacology and biomedical sciences and has held leadership roles in national health research ethics, including chairing the National Health Research Ethics Council.Prof. Parks Makhoahle is a distinguished member of the Golden Key International Honour Society. He earned his BSc in Microbiology and Biotechnology, B.Med.Sc Hons, and M.MedSc in Medical Microbiology and Virology from the University of Free State, along with a D.H.Sc in Biomedical Technology and a PGDIPHE from the Central University of Technology. Currently, he is pursuing a second doctorate in educational studies and serves as the interim Director of the Centre for Quality of Health and Living. His research focuses on the anti-cancer properties of natural products, genotoxicity, and preventing mycotoxin-induced carcinogenicity, collaborating with UFS, NHLS, and WHO-Lesotho. With over 30 peer-reviewed publications and a book chapter, he supervises nine master's students and two PhD candidates. A registered medical biological scientist, he is also a reviewer for NRF and a recipient of the multi-Vice-Chancellor’s Awards, contributing to the establishment of CUT’s advanced Biochemistry and Tissue Culture facility. Arun Kumar Singh is an Assistant Professor in the Department of Pharmacy at University School of Pharmaceutical Sciences, Rayat Bahra University V.P.O. Sahauran, India. He completed his M.Pharm in Pharmaceutics from Galgotias University, Greater Noida. His research interests include nano-formulation, blockchain, IoT, machine learning, artificial intelligence, big data analytics, cancer biology, and neuroscience. He has contributed to academic books and book chapters and has published review articles in the areas of pharmaceutical sciences and healthcare technology. His work focuses on interdisciplinary approaches integrating pharmaceutical research with emerging digital and computational technologies.

Select Guide Rating

• 1. An Overview of 3D Bioprinting in Cancer Therapy1. An Overview of 3D Bioprinting in Cancer Therapy2. 3D Bioprinted Cancer Models: Bridging Basic Biology and Drug Development3. Advancing Anti-Cancer Therapy: The Role of Three-Dimensional (3D) Bioprinting4. 3D Printing for Cancer Diagnosis and Treatment monitoring5. 3D printing: Biological printing ink, printing method for Cancer Therapy6. 3D Printing in Biomedicine: Transforming Personalized Cancer Care7. 3D Bioprinting Technology for tumor Cell Modelling and Tumor Therapy8. Biomaterials Integrated 3D Bioprinting: Transforming High-Throughput Drug Screening in Cancer Therapy9. Tissue Engineering with 3D Bioprinting: Pioneering the Future of Cancer Therapy10. Therapeutic Precision: Harnessing 3D Printing for Drug Delivery for Cancer Therapy11. Combinational Gene Therapy for Cancer: Nanoplatform-Based Strategies and Principles12. Gene Therapy and Bioprinting Synergy for cancer immunotherapy13. Innovations in 3D Bioprinting: Shaping the Future of Cancer Biology and Precision Medicine14. In silico techniques, artificial intelligence, and machine learning for 3D Bioprinting in Oncology15. Clinical trials, regulatory frameworks, and ethical considerations surrounding 3D bioprinting in cancer treatment16. Current and Future Perspective of 3D Bioprinting in Oncology

Anand Krishnan is Principal Investigator in Chemical Pathology at the Faculty of Health Sciences, University of the Free State, South Africa, where he leads the Precision Medicine Integrative Nano Diagnostics (P-MIND) laboratories. His research focuses on the biological functions of extracellular vesicles in synthetic biology, including cell surface protein modification, biomarker discovery using liquid biopsy-derived extracellular vesicles, and the role of circulating biomarkers in disease development and stem cell biology. He leads multidisciplinary research in precision medicine and nanoscale diagnostics, with a particular interest in translational applications of extracellular vesicle science. Krishnan is an active member of the International Society for Extracellular Vesicles, the African Organisation for Research and Training in Cancer, and the American Association for Cancer Research. He has also served in editorial roles supporting scientific research and publishing. Professor Mamello Sekhoacha is an Associate Professor of Pharmacology at the University of the Free State and a former Specialist Scientist at the South African Medical Research Council. She earned her Ph.D. in Pharmacology from the University of Cape Town in 2008 and holds a BSc in Biochemistry and Microbiology, an honors degree in Pharmacology, and a Postgraduate Diploma in Business Administration. Additionally, she is a qualified Clinical Research Associate (CRA) with expertise in Ethics and Governance and Executive Leadership in Academia.With over 18 years in pharmacology research, Prof. Sekhoacha focuses on drug discovery and the scientific development of medicinal plants for treating ailments like cancer and HIV. Her research addresses challenges in chemoresistance and toxicity, exploring personalized chemotherapy and targeted drug delivery systems. She has published extensively in pharmacology and biomedical sciences and has held leadership roles in national health research ethics, including chairing the National Health Research Ethics Council.Prof. Parks Makhoahle is a distinguished member of the Golden Key International Honour Society. He earned his BSc in Microbiology and Biotechnology, B.Med.Sc Hons, and M.MedSc in Medical Microbiology and Virology from the University of Free State, along with a D.H.Sc in Biomedical Technology and a PGDIPHE from the Central University of Technology. Currently, he is pursuing a second doctorate in educational studies and serves as the interim Director of the Centre for Quality of Health and Living. His research focuses on the anti-cancer properties of natural products, genotoxicity, and preventing mycotoxin-induced carcinogenicity, collaborating with UFS, NHLS, and WHO-Lesotho. With over 30 peer-reviewed publications and a book chapter, he supervises nine master's students and two PhD candidates. A registered medical biological scientist, he is also a reviewer for NRF and a recipient of the multi-Vice-Chancellor’s Awards, contributing to the establishment of CUT’s advanced Biochemistry and Tissue Culture facility. Arun Kumar Singh is an Assistant Professor in the Department of Pharmacy at University School of Pharmaceutical Sciences, Rayat Bahra University V.P.O. Sahauran, India. He completed his M.Pharm in Pharmaceutics from Galgotias University, Greater Noida. His research interests include nano-formulation, blockchain, IoT, machine learning, artificial intelligence, big data analytics, cancer biology, and neuroscience. He has contributed to academic books and book chapters and has published review articles in the areas of pharmaceutical sciences and healthcare technology. His work focuses on interdisciplinary approaches integrating pharmaceutical research with emerging digital and computational technologies.

Select Guide Rating

• 1. An Overview of 3D Bioprinting in Cancer Therapy1. An Overview of 3D Bioprinting in Cancer Therapy2. 3D Bioprinted Cancer Models: Bridging Basic Biology and Drug Development3. Advancing Anti-Cancer Therapy: The Role of Three-Dimensional (3D) Bioprinting4. 3D Printing for Cancer Diagnosis and Treatment monitoring5. 3D printing: Biological printing ink, printing method for Cancer Therapy6. 3D Printing in Biomedicine: Transforming Personalized Cancer Care7. 3D Bioprinting Technology for tumor Cell Modelling and Tumor Therapy8. Biomaterials Integrated 3D Bioprinting: Transforming High-Throughput Drug Screening in Cancer Therapy9. Tissue Engineering with 3D Bioprinting: Pioneering the Future of Cancer Therapy10. Therapeutic Precision: Harnessing 3D Printing for Drug Delivery for Cancer Therapy11. Combinational Gene Therapy for Cancer: Nanoplatform-Based Strategies and Principles12. Gene Therapy and Bioprinting Synergy for cancer immunotherapy13. Innovations in 3D Bioprinting: Shaping the Future of Cancer Biology and Precision Medicine14. In silico techniques, artificial intelligence, and machine learning for 3D Bioprinting in Oncology15. Clinical trials, regulatory frameworks, and ethical considerations surrounding 3D bioprinting in cancer treatment16. Current and Future Perspective of 3D Bioprinting in Oncology

Anand Krishnan is Principal Investigator in Chemical Pathology at the Faculty of Health Sciences, University of the Free State, South Africa, where he leads the Precision Medicine Integrative Nano Diagnostics (P-MIND) laboratories. His research focuses on the biological functions of extracellular vesicles in synthetic biology, including cell surface protein modification, biomarker discovery using liquid biopsy-derived extracellular vesicles, and the role of circulating biomarkers in disease development and stem cell biology. He leads multidisciplinary research in precision medicine and nanoscale diagnostics, with a particular interest in translational applications of extracellular vesicle science. Krishnan is an active member of the International Society for Extracellular Vesicles, the African Organisation for Research and Training in Cancer, and the American Association for Cancer Research. He has also served in editorial roles supporting scientific research and publishing. Professor Mamello Sekhoacha is an Associate Professor of Pharmacology at the University of the Free State and a former Specialist Scientist at the South African Medical Research Council. She earned her Ph.D. in Pharmacology from the University of Cape Town in 2008 and holds a BSc in Biochemistry and Microbiology, an honors degree in Pharmacology, and a Postgraduate Diploma in Business Administration. Additionally, she is a qualified Clinical Research Associate (CRA) with expertise in Ethics and Governance and Executive Leadership in Academia.With over 18 years in pharmacology research, Prof. Sekhoacha focuses on drug discovery and the scientific development of medicinal plants for treating ailments like cancer and HIV. Her research addresses challenges in chemoresistance and toxicity, exploring personalized chemotherapy and targeted drug delivery systems. She has published extensively in pharmacology and biomedical sciences and has held leadership roles in national health research ethics, including chairing the National Health Research Ethics Council.Prof. Parks Makhoahle is a distinguished member of the Golden Key International Honour Society. He earned his BSc in Microbiology and Biotechnology, B.Med.Sc Hons, and M.MedSc in Medical Microbiology and Virology from the University of Free State, along with a D.H.Sc in Biomedical Technology and a PGDIPHE from the Central University of Technology. Currently, he is pursuing a second doctorate in educational studies and serves as the interim Director of the Centre for Quality of Health and Living. His research focuses on the anti-cancer properties of natural products, genotoxicity, and preventing mycotoxin-induced carcinogenicity, collaborating with UFS, NHLS, and WHO-Lesotho. With over 30 peer-reviewed publications and a book chapter, he supervises nine master's students and two PhD candidates. A registered medical biological scientist, he is also a reviewer for NRF and a recipient of the multi-Vice-Chancellor’s Awards, contributing to the establishment of CUT’s advanced Biochemistry and Tissue Culture facility. Arun Kumar Singh is an Assistant Professor in the Department of Pharmacy at University School of Pharmaceutical Sciences, Rayat Bahra University V.P.O. Sahauran, India. He completed his M.Pharm in Pharmaceutics from Galgotias University, Greater Noida. His research interests include nano-formulation, blockchain, IoT, machine learning, artificial intelligence, big data analytics, cancer biology, and neuroscience. He has contributed to academic books and book chapters and has published review articles in the areas of pharmaceutical sciences and healthcare technology. His work focuses on interdisciplinary approaches integrating pharmaceutical research with emerging digital and computational technologies.

Select Guide Rating

• 1. An Overview of 3D Bioprinting in Cancer Therapy1. An Overview of 3D Bioprinting in Cancer Therapy2. 3D Bioprinted Cancer Models: Bridging Basic Biology and Drug Development3. Advancing Anti-Cancer Therapy: The Role of Three-Dimensional (3D) Bioprinting4. 3D Printing for Cancer Diagnosis and Treatment monitoring5. 3D printing: Biological printing ink, printing method for Cancer Therapy6. 3D Printing in Biomedicine: Transforming Personalized Cancer Care7. 3D Bioprinting Technology for tumor Cell Modelling and Tumor Therapy8. Biomaterials Integrated 3D Bioprinting: Transforming High-Throughput Drug Screening in Cancer Therapy9. Tissue Engineering with 3D Bioprinting: Pioneering the Future of Cancer Therapy10. Therapeutic Precision: Harnessing 3D Printing for Drug Delivery for Cancer Therapy11. Combinational Gene Therapy for Cancer: Nanoplatform-Based Strategies and Principles12. Gene Therapy and Bioprinting Synergy for cancer immunotherapy13. Innovations in 3D Bioprinting: Shaping the Future of Cancer Biology and Precision Medicine14. In silico techniques, artificial intelligence, and machine learning for 3D Bioprinting in Oncology15. Clinical trials, regulatory frameworks, and ethical considerations surrounding 3D bioprinting in cancer treatment16. Current and Future Perspective of 3D Bioprinting in Oncology